<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04683562</url>
  </required_header>
  <id_info>
    <org_study_id>PA-NT1</org_study_id>
    <nct_id>NCT04683562</nct_id>
  </id_info>
  <brief_title>Netrin-1 and Placenta Accreta</brief_title>
  <official_title>The Implication of Placental Netrin-1 Receptor DCC in the Pathophysiology of Placenta Accreta</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Netrin-1 is a secreted protein, which was first identified as a neuronal guidance factor. It&#xD;
      is expressed in a multitude of tissues as pancreas, lung, breast, and placenta. Netrin-1 is a&#xD;
      multifunctional protein, involved in cell polarity, adhesion, angiogenesis, apoptosis,&#xD;
      migration, morphogenesis, and differentiation of various cell types. Most of netrin-1&#xD;
      activity occur through signaling pathways induced by its two main receptors, DCC (deleted in&#xD;
      colorectal cancer) and UNC5H (uncoordinated-5 homolog). Its receptors have been linked to the&#xD;
      processes of apoptosis and angiogenesis. In absence of netrin-1, DCC and UNC5H receptors lead&#xD;
      to apoptosis. In contrary, in presence of netrin-1, receptors transduce molecular cascades&#xD;
      leading to proliferation, differentiation and migration of the cells. Netrin-1 has been&#xD;
      involved in the pathogenesis of multiple diseases, as diabetes, cardiovascular diseases, and&#xD;
      cancer. Serum Netrin-1 levels were high in preeclamptic patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 2021</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Placental Netrin-1 level</measure>
    <time_frame>4 weeks</time_frame>
    <description>will be measured by using enzyme-linked immunosorbent assay (ELÄ°SA) in placental homogenate</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Placenta Accreta</condition>
  <arm_group>
    <arm_group_label>Normal pregnancy group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placenta accreta group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pregnant women at 28-32 weeks</intervention_name>
    <description>Pregnant women at gestational age 28-32 weeks</description>
    <arm_group_label>Normal pregnancy group</arm_group_label>
    <arm_group_label>Placenta accreta group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>at delivery</intervention_name>
    <description>women delivered at term</description>
    <arm_group_label>Normal pregnancy group</arm_group_label>
    <arm_group_label>Placenta accreta group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 20-40 years.&#xD;
&#xD;
          -  Singleton pregnancy.&#xD;
&#xD;
          -  Women with suspicion of PA by two-dimensional (2D) gray scale imaging and color&#xD;
             Doppler flow mapping&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Multiple pregnancy,&#xD;
&#xD;
          -  Fetal anomalies,&#xD;
&#xD;
          -  Preterm premature rupture of membranes, or infection&#xD;
&#xD;
          -  Any medical disorders, such as thyroid dysfunction, hypertension, and gestational&#xD;
             diabetes&#xD;
&#xD;
          -  Patients with known bleeding disorders or on anticoagulant therapy.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Woman's Health Hospital</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Ali, MD</last_name>
      <phone>+201005537951</phone>
      <email>m_khairy2001@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 21, 2020</study_first_submitted>
  <study_first_submitted_qc>December 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2020</study_first_posted>
  <last_update_submitted>December 23, 2020</last_update_submitted>
  <last_update_submitted_qc>December 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohammed Khairy Ali</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

